Perdiquez, Alyanna Jean A.
HRN: 22-44-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/26/2023
CEFUROXIME 500MG (TAB)
01/26/2023
02/02/2023
ORAL
500mg
BID
S/P NSVD With RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes